250 related articles for article (PubMed ID: 1083749)
1. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
de Vaan GA; Bakkeren JA; Schretlen ED
Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
[TBL] [Abstract][Full Text] [Related]
2. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
Isaković K; Lenert G
Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of antihuman thymocyte serum with acute leukemic blasts.
Mills B; Sen L; Borella L
J Immunol; 1975 Oct; 115(4):1038-44. PubMed ID: 1100719
[TBL] [Abstract][Full Text] [Related]
5. Surface markers and prognostic factors in acute lymphoblastic leukemia.
Tsukimoto I; Wong KY; Lampkin BC
N Engl J Med; 1976 Jan; 294(5):245-8. PubMed ID: 53789
[TBL] [Abstract][Full Text] [Related]
6. E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells.
Borella L; Sen L
J Immunol; 1975 Jan; 114(1 Pt 1):187-90. PubMed ID: 1089710
[TBL] [Abstract][Full Text] [Related]
7. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte immunological patterns in leukaemia: a review.
Atsaldi G; Astaldi GC; Topuz U; Guarina L
Haematologia (Budap); 1975; 9(1-2):21-33. PubMed ID: 780227
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
Sasaki M; Sekizawa T; Takahashi H; Abo T; Kumagai K
J Immunol; 1975 Dec; 115(6):1509-14. PubMed ID: 1081102
[TBL] [Abstract][Full Text] [Related]
11. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.
Parkman R; Cohen G; Carter SL; Weinberg KI; Masinsin B; Guinan E; Kurtzberg J; Wagner JE; Kernan NA
Biol Blood Marrow Transplant; 2006 Sep; 12(9):919-27. PubMed ID: 16920557
[TBL] [Abstract][Full Text] [Related]
12. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states.
Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L
J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
14. Human thymus cells: blastogenic response to mitogens, antigens and allogeneic cells.
Han T; Minowada J; Subramanian S; Sinks LF
Immunology; 1976 Oct; 31(4):519-25. PubMed ID: 135725
[TBL] [Abstract][Full Text] [Related]
15. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
18. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
Tubiana N; Derre M; Carcassonne Y
Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
[TBL] [Abstract][Full Text] [Related]
19. [Serological diagnosis of the antigenic markers of acute lymphatic leukaemias and non-Hodgkin lymphomas in childhood (author's transl)].
Thränhardt H; Zintl F; Plenert W
Arch Geschwulstforsch; 1978; 48(4):289-300. PubMed ID: 308796
[TBL] [Abstract][Full Text] [Related]
20. PHA stimulation of separated human lymphocyte populations.
Potter MR; Moore M
Clin Exp Immunol; 1975 Sep; 21(3):456-67. PubMed ID: 1106926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
